Jared Gollob, Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR), sold 3,114 shares at $60.00 ($187K) on 2025-10-13, disclosed to the SEC on 2025-10-14.
Scheduled sale ($187k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KYMR | SELL | 2025-10-15 | $7.3M | — | Filing → |
| KYMR | SELL | 2025-03-03 | $317K | — | Filing → |
| KYMR | SELL | 2024-07-16 | $3.6M | — | Filing → |